NCT05383521View on ClinicalTrials.gov

Safety and Efficacy of Two Oral Tinidazole Regimens for Refractory Trichomonas Vaginitis

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Trichomonas Vaginitis
Interventions
DRUG

Tinidazole 56

Tinidazole , 2g， twice daily for 14 days. At the same time, metronidazole, 400 mg, once a day, vaginal administration, 14 days.

DRUG

Tinidazole 42

Tinidazole , 1g, three times daily for 14 days. At the same time, metronidazole, 400 mg, once a day, vaginal administration, 14 days.

Trial Locations (4)

518000

Peking University Shenzhen Hospital, Shenzhen

Unknown

Beijing Obstetrics and Gynecology Hospital,Capital Medical University, Beijing

Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing

Peking University First Hospital, Beijing

All Listed Sponsors
lead

Shangrong Fan

OTHER

NCT05383521 - Safety and Efficacy of Two Oral Tinidazole Regimens for Refractory Trichomonas Vaginitis | Biotech Hunter | Biotech Hunter